Schneider MB - Search Results

1

The pattern of xenobiotic-metabolizing enzymes in the human pancreas.

Standop J, Schneider MB, Ulrich A, Chauhan S, Moniaux N, Büchler MW, Batra SK, Pour PM. Standop J, et al. Among authors: schneider mb. J Toxicol Environ Health A. 2002 Oct 11;65(19):1379-400. doi: 10.1080/00984100290071603. J Toxicol Environ Health A. 2002. PMID: 12396872

2

Differences in immunohistochemical expression of xenobiotic-metabolizing enzymes between normal pancreas, chronic pancreatitis and pancreatic cancer.

Standop J, Schneider M, Ulrich A, Büchler MW, Pour PM. Standop J, et al. Toxicol Pathol. 2003 Sep-Oct;31(5):506-13. doi: 10.1080/01926230390226041. Toxicol Pathol. 2003. PMID: 14692619

3

Differences in the expression of glutathione S-transferases in normal pancreas, chronic pancreatitis, secondary chronic pancreatitis, and pancreatic cancer.

Ulrich AB, Schmied BM, Standop J, Schneider MB, Lawson TA, Friess H, Andrén-Sandberg A, Büchler MW, Pour PM. Ulrich AB, et al. Among authors: schneider mb. Pancreas. 2002 Apr;24(3):291-7. doi: 10.1097/00006676-200204000-00013. Pancreas. 2002. PMID: 11893938

4

Species differences in the distribution of drug-metabolizing enzymes in the pancreas.

Ulrich AB, Standop J, Schmied BM, Schneider MB, Lawson TA, Pour PM. Ulrich AB, et al. Among authors: schneider mb. Toxicol Pathol. 2002 Mar-Apr;30(2):247-53. doi: 10.1080/019262302753559588. Toxicol Pathol. 2002. PMID: 11950168

5

Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.

Standop J, Ulrich AB, Schneider MB, Büchler MW, Pour PM. Standop J, et al. Among authors: schneider mb. Pancreatology. 2002;2(6):510-8. doi: 10.1159/000066093. Pancreatology. 2002. PMID: 12435863

6

Expression of drug-metabolizing enzymes in the pancreas of hamster, mouse, and rat, responding differently to the pancreatic carcinogenicity of BOP.

Ulrich AB, Standop J, Schmied BM, Schneider MB, Lawson TA, Pour PM. Ulrich AB, et al. Among authors: schneider mb. Pancreatology. 2002;2(6):519-27. doi: 10.1159/000066094. Pancreatology. 2002. PMID: 12435864

7

ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.

Standop J, Schneider M, Ulrich A, Mathiak G, Brand RE, Buechler MW, Pour PM. Standop J, et al. Oncol Rep. 2004 Dec;12(6):1309-15. Oncol Rep. 2004. PMID: 15547756

8

ErbB2 growth factor receptor, a marker for neuroendocrine cells?

Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Büchler MW, Adrian TE, Batra SK, Pour PM. Standop J, et al. Pancreatology. 2005;5(1):44-58. doi: 10.1159/000084490. Epub 2005 Mar 15. Pancreatology. 2005. PMID: 15775699

9

Pancreatic cell lines: a review.

Ulrich AB, Schmied BM, Standop J, Schneider MB, Pour PM. Ulrich AB, et al. Among authors: schneider mb. Pancreas. 2002 Mar;24(2):111-20. doi: 10.1097/00006676-200203000-00001. Pancreas. 2002. PMID: 11854615 Review.

10

Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.

Matsuzaki H, Schmied BM, Ulrich A, Standop J, Schneider MB, Batra SK, Picha KS, Pour PM. Matsuzaki H, et al. Among authors: schneider mb. Clin Cancer Res. 2001 Feb;7(2):407-14. Clin Cancer Res. 2001. PMID: 11234897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page